Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
Mara Goldstein Upgraded (ADAP) to Strong Buy and Held Target at $9 on, Nov 9th, 2022
Mara Goldstein of Mizuho, Upgraded "Adaptimmune Therapeutics plc" (ADAP) to Strong Buy and Held Target at $9 on, Nov 9th, 2022.
Mara has made no other calls on ADAP in the last 4 months.
There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, all agrees with Mara's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nick Abbott of "Wells Fargo" Maintained at Hold with Decreased Target to $1.5 on, Tuesday, October 4th, 2022
